Results indicated that IDG and DXM significantly inhibited the expression of IL-6, IL-17A, MCP-1, and TNF-α in psoriasis-like lesions, with all findings reaching statistical significance, while the effect on IL-13 was not statistically significant (Table 2). The gene discussed is IL17A; the disease is psoriasis.